Terminated OBSERVATIONAL NCT02104154

Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting

Sponsor: Samsung Electronics

Interventions Samsung LABGEO PT10 Hepatic Panel

Updated 11 times since 2017 Last updated: Feb 18, 2015 Started: Nov 30, 2013 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

To conduct interim analysis and assess whether assay changes are recommended.

Listed as NCT02104154, this observational or N/A phase trial focuses on Hepatic Disease and remains terminated or withdrawn. Sponsored by Samsung Electronics, it has been updated 11 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated
Nov 2020 — Jan 2021 [monthly]

Terminated

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Terminated NA
Feb 2017 — Aug 2017 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Samsung Electronics

Data source: Samsung Electronics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States